华东医药：2022年第一季度报告（英文版）.PDF

1、The First Quarterly Report 2022 of Huadong Medicine Co.,Ltd.1 Stock code:000963 Stock abbreviation:Huadong Medicine Announcement No.:2022-022 Huadong Medicine Co.,Ltd.The First Quarterly Report 2022 The Company and all members of the Board of Directors hereby guarantee that the information presented

2、 in this report is authentic,accurate and complete and free of any false records,misleading statements or material omissions.Important Declaration:1.The Board of Directors,Board of Supervisors,directors,supervisors and senior management of Huadong Medicine Co.,Ltd.(hereinafter referred to as the“Com

3、pany”)hereby guarantee that the information presented in this report is authentic,accurate and complete and free of any false records,misleading statements or material omissions,and shall undertake individual and joint legal liabilities.2.The Companys legal representative and the officer in charge o

4、f accounting,and head of accounting department(accounting supervisor)hereby declare and guarantee that the financial statements in this quarter report are authentic,accurate and complete.3.Has the first quarterly report been audited?Yes No This report is prepared both in Chinese and English.Should t

5、here be any discrepancy between the Chinese and English versions,the Chinese version shall prevail.I.Key financial data(I)Key Accounting Data and Financial Indicators Whether the Company needs to perform retroactive adjustment or restatement of previous accounting data Yes No The current reporting p

6、eriod Same period last year Change of the current reporting period over the same period last year Operating revenue(yuan)8,932,579,251.75 8,896,632,277.36 0.40%The First Quarterly Report 2022 of Huadong Medicine Co.,Ltd.2 Net profit attributable to shareholders of listed companies(yuan)704,364,775.1